US Broker Ratings

Legend Biotech Corporation (LEGN): Analyst Consensus Signals a Potential 165% Upside

Legend Biotech Corporation (NASDAQ: LEGN) presents a compelling proposition for investors keen on the biotech sector, particularly in the realm of innovative cancer therapies. With a..

BrightSpring Health Services (BTSG) Stock Analysis: A Promising 14.97% Upside in Healthcare

BrightSpring Health Services, Inc. (BTSG), a key player in the healthcare sector, has been capturing investor attention with its robust growth prospects and strategic positioning in..

Elanco Animal Health (ELAN): Investor Outlook with an 8.24% Potential Upside

Elanco Animal Health Incorporated (NYSE: ELAN) presents a compelling investment narrative within the healthcare sector, specifically in the niche of drug manufacturing for specialty and generic..

Guardant Health, Inc. (GH) Stock Analysis: A Look at the 38.5% Revenue Growth and Investor Ratings

Guardant Health, Inc. (NASDAQ: GH), a leader in the precision oncology sector, has captured the attention of investors with its impressive 38.5% revenue growth. Based in..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 35.91% Upside in the Health Information Services Sector

Doximity, Inc. (NYSE: DOCS) has positioned itself as a major player within the healthcare sector, specifically in health information services, by providing a digital platform designed..

Akero Therapeutics (AKRO) Stock Analysis: A Look at Its Growth Potential and Market Position

Akero Therapeutics, Inc. (NASDAQ: AKRO) is capturing the attention of biotech investors with its promising pipeline and strategic focus on metabolic diseases. Headquartered in South San..

West Pharmaceutical Services, Inc. (WST): Unlocking a 29.4% Upside with Strong Growth Potential

West Pharmaceutical Services, Inc. (NYSE: WST), a stalwart in the healthcare sector, is capturing attention with its robust potential upside of 29.4%, positioning itself as a..

Option Care Health, Inc. (OPCH) Investor Outlook: Decoding a 19.38% Potential Upside

Option Care Health, Inc. (NASDAQ: OPCH) is drawing attention in the healthcare sector, particularly for its distinct position within the medical care facilities industry. With a..

Krystal Biotech, Inc. (KRYS): Investor Outlook with a Strong Buy Consensus and 5.18% Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS) has emerged as a compelling player in the biotechnology sector, capturing the attention of investors with its innovative approach to addressing..

Stevanato Group S.p.A. (STVN) Stock Analysis: Healthcare Innovator with a 28.65% Upside Potential

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, is drawing considerable investor attention with its promising upside potential of 28.65%. As a..

Bruker Corporation (BRKR) Stock Analysis: A Look at Analyst Ratings and Growth Potential

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector specializing in medical devices, presents a unique investment opportunity for those intrigued by its scientific..

ADMA Biologics Inc (ADMA) Stock Analysis: Unveiling a 58% Upside Potential for Investors

ADMA Biologics Inc (NASDAQ: ADMA), a burgeoning player in the biotechnology sector, is capturing investor attention with its promising growth trajectory and a notable potential upside..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Unpacking the 12.25% Potential Upside

Smith & Nephew SNATS, Inc. (NYSE: SNN), a prominent player in the healthcare sector, operates within the medical devices industry and boasts a market capitalization of..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring the 32.84% Potential Upside

AptarGroup, Inc. (ATR) stands as a notable player in the healthcare sector, particularly within the medical instruments and supplies industry. Based in the United States, this..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Navigating a 10.37% Potential Upside in the Healthcare Sector

Bausch + Lomb Corporation (NYSE: BLCO) is a significant player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization..

Repligen Corporation (RGEN) Stock Analysis: Navigating a 15% Potential Upside with Robust Revenue Growth

Repligen Corporation (NASDAQ: RGEN) has emerged as a formidable player in the healthcare sector, specifically within the Medical Instruments & Supplies industry. This Massachusetts-based life sciences..

Baxter International Inc. (BAX) Investor Outlook: Analyzing Growth Potential and Valuation Metrics

Baxter International Inc. (NYSE: BAX) operates within the healthcare sector, specifically in the medical instruments and supplies industry. As a stalwart in healthcare solutions, Baxter International..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Strong Buy Ratings and a 22.81% Potential Upside

BridgeBio Pharma, Inc. (NASDAQ: BBIO) has emerged as a compelling player in the biotechnology sector with a market capitalization of $13.13 billion. Headquartered in Palo Alto,..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Promising 8.05% Upside in the Biotech Sector

Halozyme Therapeutics, Inc. (NASDAQ: HALO) presents a compelling opportunity within the biotechnology industry, a sector renowned for its innovation and rapid growth. With a market capitalization..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Navigating the Biotech Terrain with a 5.25% Potential Upside

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands at the forefront of the biotechnology sector, particularly in the niche of RNA-targeted therapeutics and gene therapies aimed at treating..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds